+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Erlotinib"

From
Lung Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Lung Cancer Therapeutics - Global Strategic Business Report

  • Report
  • March 2025
  • 359 Pages
  • Global
From
Non-Small Cell Lung Cancer (NSCLC) Market Report 2025 - Product Thumbnail Image

Non-Small Cell Lung Cancer (NSCLC) Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Pancreatic Cancer Drugs Market Report 2025 - Product Thumbnail Image

Pancreatic Cancer Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Lung Cancer Therapeutics Market 2025-2033 - Product Thumbnail Image

Lung Cancer Therapeutics Market 2025-2033

  • Report
  • March 2025
  • 140 Pages
  • Global
From
Advanced Non-Squamous & Squamous NSCLC - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Non-Squamous & Squamous NSCLC - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 60 Pages
  • Global
From
From
Pancreatic Cancer Pipeline Analysis Report - Product Thumbnail Image

Pancreatic Cancer Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
From
From
From
Tarceva - Product Thumbnail Image

Tarceva

  • Report
  • August 2018
  • 25 Pages
  • Global
From
Loading Indicator

Erlotinib is an oncology drug used to treat certain types of cancer, such as non-small cell lung cancer, pancreatic cancer, and head and neck cancer. It is a tyrosine kinase inhibitor, meaning it works by blocking the action of certain proteins that are involved in the growth and spread of cancer cells. Erlotinib is taken orally and is usually prescribed in combination with other cancer treatments. Common side effects include nausea, diarrhea, rash, and fatigue. Erlotinib is a widely used drug in the oncology market, with many generic and branded versions available. It is approved by the US Food and Drug Administration (FDA) and is available in many countries around the world. Some companies in the Erlotinib market include AstraZeneca, Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more